Constitutional translocation (8;13) in a patient with non-Hodgkin's lymphoma
Por:
Salles M.-T., Neyra O., Taja L., Cervantes G., Gagnière M., Cerrillo M., Mohar A., Osornio A., Reynoso E., Gorodezky G., Sobrevilla-Calvo P.
Publicada:
1 ene 1992
Resumen:
We report a case of non-Hodgkin's lymphoma in a 16-year-old male, whose peripheral white blood cells have a t(8;13)(q24;q14). There are no previous reports that describe this association. Although the tumor cells were not studies, we discuss the possible link between this finding and the development of the malignant lymphoma. © 1992.
Filiaciones:
Salles M.-T.:
Department of Cytogenetics, Instituto Nacional de Cancerología, México City, Mexico
Department of Hematology, Instituto Nacional de Cancerología, Mexico City, Mexico
Department of Cytogenetics, Centro Hospitalario 20 de Noviembre, ISSSTE, México City, Mexico
Neyra O.:
Department of Cytogenetics, Instituto Nacional de Cancerología, México City, Mexico
Department of Hematology, Instituto Nacional de Cancerología, Mexico City, Mexico
Department of Cytogenetics, Centro Hospitalario 20 de Noviembre, ISSSTE, México City, Mexico
Taja L.:
Department of Cytogenetics, Instituto Nacional de Cancerología, México City, Mexico
Department of Hematology, Instituto Nacional de Cancerología, Mexico City, Mexico
Department of Cytogenetics, Centro Hospitalario 20 de Noviembre, ISSSTE, México City, Mexico
Cervantes G.:
Department of Cytogenetics, Instituto Nacional de Cancerología, México City, Mexico
Department of Hematology, Instituto Nacional de Cancerología, Mexico City, Mexico
Department of Cytogenetics, Centro Hospitalario 20 de Noviembre, ISSSTE, México City, Mexico
Gagnière M.:
Department of Cytogenetics, Instituto Nacional de Cancerología, México City, Mexico
Department of Hematology, Instituto Nacional de Cancerología, Mexico City, Mexico
Department of Cytogenetics, Centro Hospitalario 20 de Noviembre, ISSSTE, México City, Mexico
Cerrillo M.:
Department of Cytogenetics, Instituto Nacional de Cancerología, México City, Mexico
Department of Hematology, Instituto Nacional de Cancerología, Mexico City, Mexico
Department of Cytogenetics, Centro Hospitalario 20 de Noviembre, ISSSTE, México City, Mexico
Mohar A.:
Department of Cytogenetics, Instituto Nacional de Cancerología, México City, Mexico
Department of Hematology, Instituto Nacional de Cancerología, Mexico City, Mexico
Department of Cytogenetics, Centro Hospitalario 20 de Noviembre, ISSSTE, México City, Mexico
Osornio A.:
Department of Cytogenetics, Instituto Nacional de Cancerología, México City, Mexico
Department of Hematology, Instituto Nacional de Cancerología, Mexico City, Mexico
Department of Cytogenetics, Centro Hospitalario 20 de Noviembre, ISSSTE, México City, Mexico
Reynoso E.:
Department of Cytogenetics, Instituto Nacional de Cancerología, México City, Mexico
Department of Hematology, Instituto Nacional de Cancerología, Mexico City, Mexico
Department of Cytogenetics, Centro Hospitalario 20 de Noviembre, ISSSTE, México City, Mexico
Gorodezky G.:
Department of Cytogenetics, Instituto Nacional de Cancerología, México City, Mexico
Department of Hematology, Instituto Nacional de Cancerología, Mexico City, Mexico
Department of Cytogenetics, Centro Hospitalario 20 de Noviembre, ISSSTE, México City, Mexico
Sobrevilla-Calvo P.:
Department of Cytogenetics, Instituto Nacional de Cancerología, México City, Mexico
Department of Hematology, Instituto Nacional de Cancerología, Mexico City, Mexico
Department of Cytogenetics, Centro Hospitalario 20 de Noviembre, ISSSTE, México City, Mexico
|